[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.247.205. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Perspective
July 2015

Not Breathing Easier With the US FDA’s Ban on Chlorofluorocarbons in Inhalers

Author Affiliations
  • 1Department of Medicine, University of California, San Francisco
JAMA Intern Med. 2015;175(7):1086. doi:10.1001/jamainternmed.2015.1714

I recently experienced firsthand the impact of the US Food and Drug Administration’s (FDA) ban on chlorofluorocarbons as described by Jena et al.1 My daughter was home for vacation from college and needed to fill a prescription for an albuterol inhaler (Ventolin). I went to the pharmacy to pick it up, and when the pharmacist handed me the prescription, he said it would be $59.

First Page Preview View Large
First page PDF preview
First page PDF preview
×